Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ATNM

Actinium Pharmaceuticals, Inc.

Healthcare · USD

Set alert

Price alert · ATNM

All alert types
1.48 USD -0.05 -3.27%
As of Oct 30, 2026 Extended hours 1.44 -2.70%
Bid
1.48 × 1,200
Ask
1.52 × 400
1.45 Day range 1.54
0.749 52-week range 1.69
YTD
+8.82%
1 year
+4.23%
Open
1.51
Prev close
1.53
Mkt cap
46.53M
Vol
157.72K
Avg vol
187.06K
EPS
0.36
P/E
4.11
Div yield
0.00%
More statistics
Low
1.45
High
1.54
Forward P/E
-1.77
Beta
0.15
Short ratio
5.72
Inst. own
30.11%
Dividend
0.00
Ex-div date
50-d avg
1.55
200-d avg
4.86
1y target
5.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ATNM has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-8.02 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

S-5 / 5 overall

  • DCF 4
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 4
  • P/B 4

Valuation

P/E -1.2×
FY 2016: -1.7×FY 2017: -1.7×FY 2018: -1.7×FY 2019: -1.5×FY 2020: -4.3×FY 2021: -5.0×FY 2022: -7.8×FY 2023: -2.8×FY 2024: -1.0×FY 2025: -1.2×
FY 2016 5y median -2.8× FY 2025
P/S 471×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 108×FY 2022: 250×FY 2023: 1668×FY 2024: 0.0×FY 2025: 471×
FY 2016 5y median 250× FY 2025
P/B 5.4×
FY 2016: 2.4×FY 2017: 3.2×FY 2018: 4.7×FY 2019: 5.8×FY 2020: 1.5×FY 2021: 1.7×FY 2022: 3.9×FY 2023: 3.7×FY 2024: 1.2×FY 2025: 5.4×
FY 2016 5y median 3.7× FY 2025
P/FCF -1.7×
FY 2016: -2.0×FY 2017: -2.1×FY 2018: -2.0×FY 2019: -1.5×FY 2020: -4.3×FY 2021: -5.9×FY 2022: 31.1×FY 2023: -2.8×FY 2024: -1.1×FY 2025: -1.7×
FY 2016 5y median -1.7× FY 2025
EV/EBITDA 0.1×
FY 2016: -0.8×FY 2017: -1.0×FY 2018: -1.2×FY 2019: -1.1×FY 2020: -1.5×FY 2021: -1.9×FY 2022: -4.7×FY 2023: -1.3×FY 2024: 0.9×FY 2025: 0.1×
FY 2016 5y median -1.3× FY 2025
EV/Sales -43.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 40.3×FY 2022: 146×FY 2023: 748×FY 2024: 0.0×FY 2025: -43.1×
FY 2016 5y median 40.3× FY 2025
FCF Yield -58.2%
FY 2016: -49.2%FY 2017: -48.7%FY 2018: -50.4%FY 2019: -66.2%FY 2020: -23.1%FY 2021: -17.0%FY 2022: 3.2%FY 2023: -35.1%FY 2024: -87.3%FY 2025: -58.2%
FY 2016 5y median -35.1% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 54.2%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -40274.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -2182.2%FY 2022: -3311.1%FY 2023: -64098.8%FY 2024: 0.0%FY 2025: -40274.4%
FY 2016 5y median -3311.1% FY 2025
Net Margin -37652.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -2165.6%FY 2022: -3205.5%FY 2023: -60269.1%FY 2024: 0.0%FY 2025: -37652.2%
FY 2016 5y median -3205.5% FY 2025
ROE -432.6%
FY 2016: -135.1%FY 2017: -194.6%FY 2018: -268.4%FY 2019: -388.0%FY 2020: -36.2%FY 2021: -33.7%FY 2022: -49.7%FY 2023: -134.2%FY 2024: -116.7%FY 2025: -432.6%
FY 2016 5y median -116.7% FY 2025
ROIC -81.4%
FY 2016: -149.1%FY 2017: -196.8%FY 2018: -262.5%FY 2019: -312.1%FY 2020: -36.1%FY 2021: -33.8%FY 2022: -32.8%FY 2023: -70.6%FY 2024: -60.8%FY 2025: -81.4%
FY 2016 5y median -60.8% FY 2025
ROA -65.5%
FY 2016: -108.0%FY 2017: -145.1%FY 2018: -158.9%FY 2019: -187.6%FY 2020: -33.5%FY 2021: -30.8%FY 2022: -28.9%FY 2023: -59.9%FY 2024: -49.7%FY 2025: -65.5%
FY 2016 5y median -49.7% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -10.0%FY 2023: -92.1%FY 2024: -100.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 13.9%
FY 2016: -8.1%FY 2017: -0.2%FY 2018: 11.5%FY 2019: 7.4%FY 2020: -1.5%FY 2021: -11.5%FY 2022: -36.6%FY 2023: -52.2%FY 2024: 18.9%FY 2025: 13.9%
FY 2016 FY 2025
EPS (diluted) 14.2%
FY 2016: 8.9%FY 2017: 20.6%FY 2018: 44.1%FY 2019: 34.7%FY 2020: 58.1%FY 2021: 34.4%FY 2022: -14.2%FY 2023: -33.6%FY 2024: 30.6%FY 2025: 14.2%
FY 2016 FY 2025
Free Cash Flow 25.4%
FY 2016: -12.1%FY 2017: -3.5%FY 2018: 4.2%FY 2019: -4.2%FY 2020: -1.6%FY 2021: 4.0%FY 2022: 139.4%FY 2023: -673.7%FY 2024: 30.3%FY 2025: 25.4%
FY 2016 FY 2025

Financial Health

Current Ratio 6.2×
FY 2016: 5.0×FY 2017: 3.8×FY 2018: 2.4×FY 2019: 1.9×FY 2020: 13.6×FY 2021: 11.7×FY 2022: 10.4×FY 2023: 9.2×FY 2024: 9.1×FY 2025: 6.2×
FY 2016 5y median 9.2× FY 2025
Quick Ratio 6.2×
FY 2016: 5.0×FY 2017: 3.8×FY 2018: 2.4×FY 2019: 1.9×FY 2020: 13.6×FY 2021: 11.7×FY 2022: 10.4×FY 2023: 9.2×FY 2024: 9.1×FY 2025: 6.2×
FY 2016 5y median 9.2× FY 2025
Debt / Equity 0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.3×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.2×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.4×
FY 2016: 0.8×FY 2017: 0.6×FY 2018: 0.6×FY 2019: 0.4×FY 2020: 2.9×FY 2021: 3.2×FY 2022: 3.3×FY 2023: 1.6×FY 2024: 1.9×FY 2025: 1.4×
FY 2016 5y median 1.9× FY 2025
Interest Coverage 0.0×
FY 2016: -5362×FY 2017: -4956×FY 2018: -137×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -0.0%FY 2020: -0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31